Delivery Order SPE2DB25D3202-SPE2DB25FTAZT
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,172.74 for Shingrix vial kits on April 24, 2025, with an ultimate completion date of April 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits valued at $1,139.18, with an ultimate completion date of August 25, 2025. This competitive, firm fixed price delivery order was issued on August 22, 2025, with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across the Department of Defense and other...
- The Defense Logistics Agency awarded a delivery order valued at $1,139.18 to AmerisourceBergen Drug Corp for Shingrix vial kits on June 2, 2025, with an ultimate completion date of June 3, 2025. This firm fixed-price contract, issued without a set-aside designation, represents a competitive award to the prime contractor for vaccine supply. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,949.80 for Shingrix vial kits under a firm fixed-price contract. The award was made on September 12, 2025, with an ultimate completion date of September 15, 2025. This delivery order represents a non-competitive award issued under an existing indefinite delivery contract vehicle, with performance to be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Shingrix vial kits, with a ceiling value of $1,544.06. This firm fixed-price delivery order is set to be completed by April 25, 2025, and represents a non-competitive continuation of AmerisourceBergen's substantial federal pharmaceutical supply relationship. The award is issued under a child contract vehicle, leveraging AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a $24,158.39 delivery order to AmerisourceBergen Drug Corp for SHINGRIX vial kits, with a completion date of July 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award to the pharmaceutical distributor. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits valued at $8,769.12, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits valued at $1,139.18, with an ultimate completion date of August 27, 2025. This non-set-aside, firm fixed price delivery order represents a competitively awarded procurement to supply vaccines supporting federal medical supply chain requirements. The contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $51,263.00 to supply Shingrix vial kits, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion through December 2026. The contract carries no set-aside designation and will be performed at...
- The Defense Logistics Agency awarded a $1,139.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits, with a completion deadline of July 14, 2025. This competitively awarded contract, issued on July 11, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug...
- SPE2DB25D3202Indefinite Delivery Contract
- SPE2DB25D3202-SPE2DB25FTAZTDelivery Order
This delivery order, valued at $1,558.34, was awarded to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Shingrix vial kits. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense responsible for supplying medical and pharmaceutical products to military and veteran healthcare systems. The contract is a firm fixed-price delivery order with an ultimate completion date of July 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used in this competitive award. This delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.9 billion global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and prime contractor to the federal government, AmerisourceBergen supplies an extensive portfolio of brand-name and generic medications, vaccines, and medical devices to support military healthcare programs worldwide. The Shingrix vial kits—a vaccine product—represent part of the company's critical role in fulfilling federal medical procurement requirements across multiple therapeutic domains and healthcare systems serving the Defense Health Agency, U.S. Coast Guard, and other government entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 7/24/25 |